CervoMed Inc. (CRVO) Tops Q3 EPS by 223c

CervoMed Inc. (NASDAQ: CRVO) reported Q3 EPS of ($0.70), $2.23 better than the analyst estimate of ($2.93). Revenue for the quarter came in at $1.52 million.

For earnings history and earnings-related data on CervoMed Inc. (CRVO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• Nvidia pitches Vera CPU to Chinese clients with August delivery target